These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 37499530)
1. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors. Ritu ; Sharma P; Gupta GD; Asati V Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li X; Li J Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents. Sayahi MH; Zareei S; Halimi M; Alikhani M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Rastegar H; Taslimi P; Ibrahim EH; Ghramh HA; Larijani B; Mahdavi M Sci Rep; 2024 Jul; 14(1):15791. PubMed ID: 38982268 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as α-glucosidase inhibitors with antidiabetic activity. Hu C; Liang B; Sun J; Li J; Xiong Z; Wang SH; Xuetao X Eur J Med Chem; 2024 Jan; 264():115957. PubMed ID: 38029465 [TBL] [Abstract][Full Text] [Related]
5. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition. Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079 [TBL] [Abstract][Full Text] [Related]
6. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives. Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation, and docking study of new triazole-phenylacetamide derivatives as α-glucosidase inhibitors. Luo S; Yang W; Huang Y; Peng Z; Wang G Bioorg Chem; 2023 Dec; 141():106844. PubMed ID: 37703743 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats. Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors. Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, Computational Study, and In Vitro α-Glucosidase Inhibitory Action of Thiourea Derivatives Based on 3-Aminopyridin-2(1 Shulgau Z; Palamarchuk I; Sergazy S; Urazbayeva A; Gulyayev A; Ramankulov Y; Kulakov I Molecules; 2024 Jul; 29(15):. PubMed ID: 39125032 [TBL] [Abstract][Full Text] [Related]
11. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies. Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191 [TBL] [Abstract][Full Text] [Related]
12. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase. Yousefnejad F; Mohammadi-Moghadam-Goozali M; Sayahi MH; Halimi M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Asadi M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M Sci Rep; 2023 Jul; 13(1):12397. PubMed ID: 37524733 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study. Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α-glucosidase. Fan M; Yang W; Liu L; Peng Z; He Y; Wang G Bioorg Chem; 2023 Mar; 132():106384. PubMed ID: 36696731 [TBL] [Abstract][Full Text] [Related]
16. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress. Kothari M; Kannan K; Sahadevan R; Sadhukhan S Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study. Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854 [TBL] [Abstract][Full Text] [Related]
18. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation. Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516 [TBL] [Abstract][Full Text] [Related]
19. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes. Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids. Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]